Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
95.46
-1.25 (-1.29%)
Feb 27, 2026, 4:00 PM EST - Market closed
Globus Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 526.16 | 784.44 | 467.29 | 150.47 | 193.07 |
Short-Term Investments | 31.09 | 105.62 | 50.5 | 295.59 | 250.38 |
Cash & Short-Term Investments | 557.24 | 890.06 | 517.79 | 446.06 | 443.45 |
Cash Growth | -37.39% | 71.90% | 16.08% | 0.59% | 3.91% |
Accounts Receivable | 678.94 | 557.7 | 503.24 | 213.25 | 164.44 |
Other Receivables | 64.73 | 20.63 | 1.64 | 4.06 | 1.22 |
Receivables | 743.67 | 578.33 | 504.87 | 217.31 | 165.65 |
Inventory | 759.28 | 659.23 | 848.14 | 298.98 | 237 |
Prepaid Expenses | 65.43 | 49.64 | 44.58 | 21 | 18.42 |
Total Current Assets | 2,126 | 2,177 | 1,915 | 983.34 | 864.52 |
Property, Plant & Equipment | 628.96 | 612.07 | 647.66 | 249.72 | 221.08 |
Long-Term Investments | 71.82 | 66.13 | 75.43 | 495.85 | 562.48 |
Goodwill | 1,435 | 1,432 | 1,435 | 197.47 | 179.71 |
Other Intangible Assets | 745.06 | 795.12 | 924.6 | 63.57 | 68.66 |
Long-Term Deferred Tax Assets | 218.22 | 94.2 | 10.69 | 48.85 | 24.49 |
Other Long-Term Assets | 78.06 | 74.58 | 77.79 | 37.32 | 36.33 |
Total Assets | 5,303 | 5,252 | 5,086 | 2,076 | 1,957 |
Accounts Payable | 98.85 | 75.12 | 56.67 | 36.1 | 21.96 |
Accrued Expenses | 281.36 | 253.61 | 230.65 | 86.61 | 87.24 |
Current Portion of Long-Term Debt | - | 443.35 | - | - | - |
Current Portion of Leases | 15.09 | 10.48 | 12.44 | 2.54 | - |
Current Income Taxes Payable | 4.16 | 10.73 | 3.85 | 0.99 | 1.05 |
Current Unearned Revenue | 27.66 | 22.14 | 18.37 | 14.1 | 12.03 |
Other Current Liabilities | 71.39 | 40.49 | 70.37 | 18.87 | 17.89 |
Total Current Liabilities | 498.5 | 855.91 | 392.35 | 159.2 | 140.16 |
Long-Term Debt | - | - | 417.4 | - | - |
Long-Term Leases | 104.35 | 83.89 | 91.37 | 3.48 | - |
Long-Term Deferred Tax Liabilities | 23.76 | 23.89 | 84.42 | 1.78 | 4.31 |
Other Long-Term Liabilities | 102.9 | 110.73 | 102.58 | 65.3 | 71.4 |
Total Liabilities | 729.51 | 1,074 | 1,088 | 229.75 | 215.88 |
Common Stock | 0.14 | 0.14 | 0.14 | 0.1 | 0.1 |
Additional Paid-In Capital | 3,170 | 3,031 | 2,871 | 630.95 | 553.79 |
Retained Earnings | 1,388 | 1,153 | 1,137 | 1,240 | 1,194 |
Comprehensive Income & Other | 15.35 | -6.86 | -10.19 | -24.63 | -6.77 |
Shareholders' Equity | 4,573 | 4,177 | 3,998 | 1,846 | 1,741 |
Total Liabilities & Equity | 5,303 | 5,252 | 5,086 | 2,076 | 1,957 |
Total Debt | 119.44 | 537.72 | 521.22 | 6.01 | - |
Net Cash (Debt) | 509.62 | 418.47 | 72 | 935.9 | 1,006 |
Net Cash Growth | 21.78% | 481.20% | -92.31% | -6.96% | 28.89% |
Net Cash Per Share | 3.72 | 3.04 | 0.63 | 9.12 | 9.71 |
Filing Date Shares Outstanding | 135.25 | 137.54 | 135.37 | 100.3 | 101.56 |
Total Common Shares Outstanding | 135.06 | 137.42 | 136.34 | 100.19 | 101.54 |
Working Capital | 1,627 | 1,321 | 1,523 | 824.14 | 724.35 |
Book Value Per Share | 33.86 | 30.40 | 29.32 | 18.43 | 17.15 |
Tangible Book Value | 2,393 | 1,950 | 1,639 | 1,585 | 1,493 |
Tangible Book Value Per Share | 17.72 | 14.19 | 12.02 | 15.82 | 14.70 |
Land | 10.85 | 9.73 | 9.75 | 8.28 | 8.3 |
Buildings | 127.57 | 100.13 | 102.45 | 51.51 | 44.67 |
Machinery | 1,072 | 956.23 | 878.41 | 508.88 | 443.25 |
Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.